Amedisys, Inc. (AMED)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Here's Why You Should Retain AMED Stock in Your Portfolio Now
Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises
Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care.
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Amedisys (AMED) Lags Q4 Earnings and Revenue Estimates
Amedisys (AMED) came out with quarterly earnings of $0.96 per share, missing the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.94 per share a year ago.
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Stocks to Gain From Trump's Family Caregiver Tax Credits
President Trump has endorsed the passage of a tax credit for family caregivers. The tax credit would be given to caregivers who take care of a parent, family member, or a loved one.
Reasons to Retain AMED Stock in Your Portfolio Now
Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
Amedisys, UnitedHealth Group Extend Deadline To Complete $3.3B Merger
UnitedHealth Group (UNH) and Amedisys (AMED) agreed to extend the deadline to complete their $3.3 billion merger, after the U.S. Department of Justice moved to block it.
Amedisys and UnitedHealth Extend Merger Deadline - What's Going On?
Amedisys Inc AMED shares are trading higher on Friday after the company announced it extended its merger deadline with UnitedHealth Group Incorporated UNH.
AMED Q3 Earnings and Revenues Miss, Margins Dip, Stock Falls
Amedisys, for the third quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care.
Amedisys (AMED) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Amedisys (AMED) Q3 Earnings and Revenues Lag Estimates
Amedisys (AMED) came out with quarterly earnings of $1 per share, missing the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $0.98 per share a year ago.
